NowoTrade

DGX

DGX Quest Diagnostics Incorporated

Stock · NYSE · United States · Healthcare · US74834L1008

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Quest Diagnostics Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 255.72 USD +0.38%
52-week range 171.18 – 259.00
Dividend yield1.35%
Market cap28.1B
NowoTrade score 63 Grade A

Price history

Daily prices in USD.

Updated 06 Nov 2026 21:06. Information, not advice.

Results

Next results 09 Feb 2027 in 94 days · 08:00 · estimate 2.68
Last results 3.00 vs 2.87 estimated 22 Oct 2026 · Beat +4.4%
Beat the estimate 11 of 12 0 missed · 1 in line · 9 beats in a row
Average surprise +4.0% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

01 Feb 2024: estimate 2.11 01 Feb 2024: reported 2.15 02/24 23 Apr 2024: estimate 1.86 23 Apr 2024: reported 2.04 04/24 23 Jul 2024: estimate 2.33 23 Jul 2024: reported 2.35 07/24 22 Oct 2024: estimate 2.26 22 Oct 2024: reported 2.30 10/24 30 Jan 2025: estimate 2.18 30 Jan 2025: reported 2.23 01/25 22 Apr 2025: estimate 2.15 22 Apr 2025: reported 2.21 04/25 22 Jul 2025: estimate 2.57 22 Jul 2025: reported 2.62 07/25 21 Oct 2025: estimate 2.50 21 Oct 2025: reported 2.60 10/25 10 Feb 2026: estimate 2.36 10 Feb 2026: reported 2.42 02/26 21 Apr 2026: estimate 2.37 21 Apr 2026: reported 2.50 04/26 23 Jul 2026: estimate 2.82 23 Jul 2026: reported 3.12 07/26 22 Oct 2026: estimate 2.87 22 Oct 2026: reported 3.00 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
09 Feb 2027 08:00 2.68 — — Upcoming
22 Oct 2026 06:00 2.87 3.00 +4.4% Beat
23 Jul 2026 06:00 2.82 3.12 +10.5% Beat
21 Apr 2026 06:00 2.37 2.50 +5.6% Beat
10 Feb 2026 06:00 2.36 2.42 +2.6% Beat
21 Oct 2025 06:00 2.50 2.60 +3.9% Beat
22 Jul 2025 06:00 2.57 2.62 +1.9% Beat
22 Apr 2025 06:00 2.15 2.21 +2.8% Beat
30 Jan 2025 06:00 2.18 2.23 +2.1% Beat
22 Oct 2024 06:00 2.26 2.30 +1.9% Beat
23 Jul 2024 06:00 2.33 2.35 +0.7% In line
23 Apr 2024 06:00 1.86 2.04 +9.8% Beat
01 Feb 2024 06:00 2.11 2.15 +1.7% Beat
24 Oct 2023 06:00 2.19 2.22 +1.4% Beat
26 Jul 2023 06:00 2.26 2.30 +1.9% Beat
27 Apr 2023 06:00 1.97 2.04 +3.5% Beat
02 Feb 2023 06:00 1.90 1.98 +4.0% Beat
20 Oct 2022 06:00 2.19 2.36 +7.6% Beat
21 Jul 2022 06:00 2.27 2.36 +3.9% Beat
21 Apr 2022 06:00 3.00 3.22 +7.3% Beat
03 Feb 2022 06:00 3.21 3.33 +3.8% Beat
21 Oct 2021 06:00 3.06 3.96 +29.2% Beat
22 Jul 2021 06:00 2.86 3.18 +11.1% Beat
22 Apr 2021 06:00 3.73 3.76 +0.7% In line
04 Feb 2021 06:00 4.24 4.48 +5.7% Beat
22 Oct 2020 06:00 3.73 4.31 +15.6% Beat
23 Jul 2020 06:00 1.25 1.42 +13.5% Beat
22 Apr 2020 07:00 0.88 0.94 +6.7% Beat
30 Jan 2020 06:00 1.60 1.67 +4.2% Beat
22 Oct 2019 06:00 1.71 1.76 +2.9% Beat
23 Jul 2019 06:00 1.68 1.73 +2.8% Beat
23 Apr 2019 06:00 1.38 1.40 +1.7% Beat
14 Feb 2019 06:00 1.37 1.36 -0.6% In line
23 Oct 2018 06:00 1.68 1.68 +0.2% In line
24 Jul 2018 06:00 1.76 1.75 -0.3% In line
19 Apr 2018 06:00 1.50 1.52 +1.2% Beat
01 Feb 2018 06:00 1.37 1.40 +1.9% Beat
19 Oct 2017 06:00 1.36 1.39 +2.6% Beat
25 Jul 2017 06:00 1.42 1.55 +9.5% Beat
20 Apr 2017 06:00 1.18 1.33 +13.2% Beat
26 Jan 2017 06:00 1.27 1.31 +3.0% Beat
20 Oct 2016 06:00 1.35 1.37 +1.3% Beat
21 Jul 2016 06:00 1.32 1.34 +1.8% Beat
21 Apr 2016 06:00 1.12 1.12 +0.1% In line
28 Jan 2016 06:00 1.19 1.19 +0.1% In line
22 Oct 2015 06:00 1.26 1.28 +1.6% Beat
23 Jul 2015 07:00 1.23 1.25 +1.2% Beat
23 Apr 2015 07:00 1.04 1.05 +0.8% In line
29 Jan 2015 07:00 1.05 1.08 +3.2% Beat
23 Oct 2014 07:00 1.08 1.10 +2.3% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 11B +11.8% 992M 9.0% 8.75 +13.8% 1.4B
2024 9.9B +6.7% 871M 8.8% 7.69 +2.7% 909M
2023 9.3B -6.4% 854M 9.2% 7.49 -6.0% 864M
2022 9.9B — 946M 9.6% 7.97 — 1.3B

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by day
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
17 Jun 2024 136.77 137.75 136.60 137.02 -0.60% 815,800
14 Jun 2024 138.00 139.18 137.01 137.85 -0.49% 718,600
13 Jun 2024 138.88 139.13 137.48 138.53 -0.22% 668,000
12 Jun 2024 141.57 141.73 138.16 138.83 -1.37% 831,200
11 Jun 2024 140.96 141.43 140.34 140.76 -0.50% 544,000
10 Jun 2024 141.97 142.20 140.43 141.47 -0.61% 589,500
07 Jun 2024 142.30 143.19 142.24 142.34 -0.21% 366,200
06 Jun 2024 142.37 143.84 142.28 142.64 -0.04% 618,400
05 Jun 2024 141.27 143.00 140.80 142.69 +0.79% 837,500
04 Jun 2024 140.97 142.01 139.71 141.57 +0.33% 818,800
03 Jun 2024 140.92 142.25 139.83 141.11 -0.61% 634,300
31 May 2024 139.58 142.06 139.39 141.97 +1.89% 2,238,000
30 May 2024 137.97 139.68 137.36 139.33 +0.82% 838,600
29 May 2024 138.13 139.07 137.34 138.19 -0.52% 986,800
28 May 2024 140.80 141.58 138.67 138.91 -1.68% 886,300
24 May 2024 140.60 141.59 139.77 141.28 +0.89% 647,500
23 May 2024 141.21 142.92 139.98 140.04 -1.28% 1,147,100
22 May 2024 142.16 143.44 141.51 141.86 -1.03% 805,700
21 May 2024 144.29 144.50 142.72 143.34 -0.58% 561,800
20 May 2024 144.16 145.62 143.90 144.17 -0.12% 1,078,800
17 May 2024 143.00 144.46 141.96 144.34 +1.34% 1,422,800
16 May 2024 140.77 142.95 140.41 142.43 +1.17% 995,900
15 May 2024 139.41 141.01 139.03 140.78 +1.16% 757,600
14 May 2024 141.04 141.18 138.10 139.16 -1.15% 741,100
13 May 2024 138.67 141.73 138.24 140.78 +1.70% 1,116,200

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

Key data

Previous close
254.74 USD
Market cap
28.1B
Dividend yield
1.35%
5-year average yield
1.82%
Payout ratio
25%
Last dividend
0.8600 USD · 06 Oct 2026
Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD

Dividends

Ex-dividend datePer share
06 Oct 20260.8600 USD
08 Jul 20260.8600 USD
06 Apr 20260.8600 USD
13 Jan 20260.8000 USD
03 Oct 20250.8000 USD
07 Jul 20250.8000 USD
07 Apr 20250.8000 USD
14 Jan 20250.7500 USD
04 Oct 20240.7500 USD
08 Jul 20240.7500 USD
05 Apr 20240.7500 USD
16 Jan 20240.7100 USD

Why this score

How the score is made up
Part of the scorePointsWhy
Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. 5.6 / 25
  • Yield of 1.4% on today's price
Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. 21.1 / 25
  • Dividend uses 32% of free cash flow (3-year average)
Dividend growth How many years in a row the dividend has risen, and how fast. 15.0 / 15
  • Dividend up 13 years in a row, 12.5% a year
Quality Return on equity, net margin and how stable the margins are. 11.2 / 15
  • ROE of 15%
Valuation Free cash flow yield and the P/E against its sector. 6.9 / 10
  • P/E 25.5 against 31.1 for its sector
Analysts How far the analysts' average target is from today's price. 1.8 / 5
  • Analysts' target is +1% from the price

Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 25.46× Weak 31.09×
P/E (forward) 21.34× Fair 14.98×
Price / book 3.68× Weak 3.87×
Price / sales 2.38× Fair 3.42×
EV / EBITDA 14.47× Fair 13.22×
Free cash flow yield 3.1% Fair 2.5%
Quality
FigureValueReading Sector median
Gross margin 33.2% Fair 59.2%
Operating margin 15.6% Good 7.8%
Net margin 9.5% Fair 3.4%
Return on equity 15.3% Good 5.9%
Return on assets 6.6% Fair 3.6%
Growth
FigureValueReading Sector median
Revenue growth / year 3.7% Fair 10.8%
EPS growth / year 3.2% Fair 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.8× Good 0.46×
Net debt / EBITDA 2.38× Fair 1.48×
Interest cover 5.62× Fair 3.26×
Current ratio 1.7× Good 2.35×
Dividends
FigureValueReading Sector median
Payout of earnings 25.1% Good 0%
Payout of free cash flow 40.5% Good 30.1%
Payout of free cash flow (3 years) 31.9% Good —
Dividend growth / year 12.5% Good 7.1%
Years of rising dividends 13 Good 2

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow DGX and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in